Diabetes is a prevalent chronic disease worldwide, with approximately 537 million adults affected, and the number is expected to double by 2030. In low- and middle-income countries like India, diabetes is a significant health issue. Elevated LDL cholesterol levels (dyslipidemia) in individuals with diabetes increase the risk of cardiovascular disease. Achieving optimal control of HbA1c, blood pressure, and LDL cholesterol, known as the ABC clinical targets, is crucial for managing cardiovascular health in diabetic patients. A multicentric study in India examined 2202 diabetes patients to assess cardiovascular risk factors. The study aimed to identify high-risk patient cohorts based on ABC goal achievement for cardiovascular disease. The study, conducted for 6 months from March to August 2022, set the following cut-offs for the ABC goals: HbA1c <7.0%, systolic BP <130 mmHg, diastolic BP <80 mmHg, and LDL-C <100 mg/dL. Results indicated that only 3.5% of all participants achieved all three ABC goals. When looking at specific patient cohorts, the percentage was even lower in younger age groups (<35 years) at 1.5%, compared to 2.9% in the 35-54 years group and higher in individuals aged 54 years and above (unspecified percentage, but significantly higher). The study also highlighted that older adult were more likely to achieve the ABC targets compared to younger adults. However, it is concerning that a considerable proportion (34.8%) of participants failed to meet any of the ABC goals within recommended limits. Another study revealed that only 44.7% of participants achieved the LDL cholesterol target. These findings underscore the need for comprehensive assessment and management of ABC goals in diabetes care to reduce mortality rates. Efforts to improve diabetes management and address associated cardiovascular risks are particularly crucial in low- and middle-income countries facing a high disease burden. Comprehensive strategies are vital for regular monitoring of BP, lipids, and glycemic control, prioritizing awareness, and adherence to guidelines, especially in higher-risk younger adults.

American Diabetes Association (ADA) 83rd Scientific Sessions, 23rd-26th June 2023, San Diego, CA.